China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation, Prediction and Health Economic Analysis of Lecanemab Efficacy Based on Multimodal Digital Behavior and Blood Biomarkers: A Prospective Observational Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132811

Registration Time: 2026/09/18

Type: Observational study

Primary Sponsor: The first hospital of Shanxi Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341077

Published by HT Digital Content Services with permission from Health Daily Digest....